Reuters logo
BRIEF-Dr.Reddy's Labs' Aurigene, Curis to start mid-stage study of CA-170
2017年9月12日 / 中午12点28分 / 2 个月前

BRIEF-Dr.Reddy's Labs' Aurigene, Curis to start mid-stage study of CA-170

Sept 12 (Reuters) - Dr.Reddy’s Laboratories Ltd:

* Says Aurigene Discovery Technologies, Curis plan to initiate phase 2 trial of CA-170 in India‍​

* Says phase 2 trial is result of initial safety data, preliminary evidence of clinical benefit observed in trial‍​ Source text: bit.ly/2xi3er8 Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below